AC Immune SA is a clinical-stage biopharma that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and NeuroOrphan indications. The Company has two clinically validated technology platforms, SupraAntigen® and Morphomer®.

Cooperation possibilities

AC Immune’s expertise and proprietary cutting-edge technologies enable the discovery of first- and best-in-class candidates. The Company has a strong track record of securing strategic partnerships with leading global pharmaceutical companies, which maximizes the value of its diversified pipeline.

Additional address info
  • EPFL Innovation Park Building B
Facts & figures
  • Type of organization
    Public company
  • Year of foundation
  • Number of employees in Switzerland
Key business

You may also be interested in